WC Bioscience Accelerator Participants

NanoLytx
Affiliations
Rockefeller University
Technologies
Therapeutic
Indication
Infectious Disease
Neurodegenerative Disease
Executive Summary
View/DownloadWebsite
nanolytx.comAdditional Information
Minority-Led
Edmondo Campisi
Leveraging our breakthrough discoveries in the pathogenesis of multiple sclerosis, we are dedicated to stopping the devastating consequences of this disease at its initial onset.